INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 433s ago
HOUSE PTR10s ago
SEC 13F3s ago
ROBINHOOD CHAIN3s ago
HOUSE PTR/PurchaseVerified data

Gilbert Ray Cisneros, Jr. bought VCYT

Self · VERACYTE, INC. · Veracyte, Inc. - Common Stock

Side
BUY
Value range
$1,001 – $15K
Shares
Not disclosed
Price
—
Executed
Mar 3, 2026
Disclosed
Apr 7, 2026
Disclosure timeline35 days from execution to publication · legal deadline 45 days
Mar 3 executedApr 7, 2026 disclosed

VCYT · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
24/ 100 · ROUTINE
Methodology →
  • Transaction type+14 / 20

    Purchase

  • Relative size+2 / 25

    Disclosed range starting at $1K

  • Filing timing+4 / 15

    Disclosed 35 days after execution (STOCK Act deadline: 45)

  • Historical behavior+4 / 15

    1 prior trade recorded in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · VCYT

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    12
    WJ
    Wygant JonathanVP, Chief Accounting Officer
    VCYTVERACYTE, INC.
    Tax withholding
    		F$66K
    1,306 sh
    		Oct 28, 2026Oct 29, 2026
    traded Oct 28, 2026
    		+1dSEC FORM 4

    Evidence

    20
    HJ
    Holstein JensDirector
    VCYTVERACYTE, INC.
    Open-market sale · 10b5-1 plan
    		SELL$375K
    7,500 sh
    		Oct 27, 2026Oct 28, 2026
    traded Oct 27, 2026
    		+1dSEC FORM 4

    Evidence

    9
    HJ
    Holstein JensDirector
    VCYTVERACYTE, INC.
    Option exercise · 10b5-1 plan
    		M$265K
    7,500 sh
    		Oct 27, 2026Oct 28, 2026
    traded Oct 27, 2026
    		+1dSEC FORM 4

    Evidence

    30
    HJ
    Holstein JensDirector
    VCYTVERACYTE, INC.
    Open-market sale · 10b5-1 plan
    		SELL$353K
    7,500 sh
    		Sep 24, 2026Oct 28, 2026
    traded Sep 24, 2026
    		+34dSEC FORM 4

    Evidence

    19
    HJ
    Holstein JensDirector
    VCYTVERACYTE, INC.
    Option exercise · 10b5-1 plan
    		M$265K
    7,500 sh
    		Sep 24, 2026Oct 28, 2026
    traded Sep 24, 2026
    		+34dSEC FORM 4

    Evidence

    7
    HJ
    Holstein JensDirector
    VCYTVERACYTE, INC.
    Option exercise · 10b5-1 plan
    		M—
    7,500 sh
    		Oct 27, 2026Oct 28, 2026
    traded Oct 27, 2026
    		+1dSEC FORM 4

    Evidence

    13
    HJ
    Holstein JensDirector
    VCYTVERACYTE, INC.
    Option exercise · 10b5-1 plan
    		M—
    7,500 sh
    		Sep 24, 2026Oct 28, 2026
    traded Sep 24, 2026
    		+34dSEC FORM 4

    Evidence

    13
    BM
    Bhanji MunaDirector
    VCYTVERACYTE, INC.
    Open-market sale · 10b5-1 plan
    		SELL$81K
    1,864 sh
    		Oct 19, 2026Oct 20, 2026
    traded Oct 19, 2026
    		+1dSEC FORM 4

    Evidence

    9
    LJ
    Leite JohnGlobal Chief Commercial Off
    VCYTVERACYTE, INC.
    Open-market sale · 10b5-1 plan
    		SELL$161K
    4,015 sh
    		Sep 21, 2026Sep 22, 2026
    traded Sep 21, 2026
    		+1dSEC FORM 4

    Evidence

    9
    CR
    Chambers RebeccaChief Financial Officer
    VCYTVERACYTE, INC.
    Open-market sale · 10b5-1 plan
    		SELL$106K
    2,477 sh
    		Sep 4, 2026Sep 4, 2026
    traded Sep 4, 2026
    		+0dSEC FORM 4

    Evidence

    8
    LJ
    Leite JohnGlobal Chief Commercial Off
    VCYTVERACYTE, INC.
    Tax withholding
    		F$178K
    3,961 sh
    		Sep 2, 2026Sep 4, 2026
    traded Sep 2, 2026
    		+2dSEC FORM 4

    Evidence

    0
    CR
    Chambers RebeccaChief Financial Officer
    VCYTVERACYTE, INC.
    Tax withholding · 10b5-1 plan
    		F$162K
    3,603 sh
    		Sep 2, 2026Sep 4, 2026
    traded Sep 2, 2026
    		+2dSEC FORM 4

    Evidence

    9
    CR
    Chambers RebeccaChief Financial Officer
    VCYTVERACYTE, INC.
    Open-market sale · 10b5-1 plan
    		SELL$51K
    1,175 sh
    		Sep 4, 2026Sep 4, 2026
    traded Sep 4, 2026
    		+0dSEC FORM 4

    Evidence

    0
    MA
    McGuire AnnieEVP, General Counsel
    VCYTVERACYTE, INC.
    Tax withholding · 10b5-1 plan
    		F$144K
    3,215 sh
    		Sep 2, 2026Sep 4, 2026
    traded Sep 2, 2026
    		+2dSEC FORM 4

    Evidence

    6
    MA
    McGuire AnnieEVP, General Counsel
    VCYTVERACYTE, INC.
    Open-market sale · 10b5-1 plan
    		SELL$92K
    2,154 sh
    		Sep 4, 2026Sep 4, 2026
    traded Sep 4, 2026
    		+0dSEC FORM 4

    Evidence

    3
    MA
    McGuire AnnieEVP, General Counsel
    VCYTVERACYTE, INC.
    Open-market sale · 10b5-1 plan
    		SELL$48K
    1,100 sh
    		Sep 4, 2026Sep 4, 2026
    traded Sep 4, 2026
    		+0dSEC FORM 4

    Evidence

    20
    ARK Investment Management LLC13F filer
    VCYTVERACYTE, INC.
    TRIM
    		SELL$44.51M
    757.9K sh
    		Not disclosedAug 14, 2026quarterlySEC 13F

    Evidence

    17
    MF
    Miller Thomas F.Director
    VCYTVERACYTE, INC.
    Grant or award
    		A—
    5,272 sh
    		Jun 11, 2026Jun 15, 2026
    traded Jun 11, 2026
    		+4dSEC FORM 4

    Evidence

    13
    BE
    Barr EliavDirector
    VCYTVERACYTE, INC.
    Grant or award
    		A—
    5,272 sh
    		Jun 11, 2026Jun 15, 2026
    traded Jun 11, 2026
    		+4dSEC FORM 4

    Evidence

    11
    MA
    McGuire AnnieEVP, General Counsel
    VCYTVERACYTE, INC.
    Open-market sale · 10b5-1 plan
    		SELL$89K
    1,776 sh
    		Jun 4, 2026Jun 4, 2026
    traded Jun 4, 2026
    		+0dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    House Periodic Transaction Report
    Publisher
    Clerk of the U.S. House of Representatives
    Document ID
    20034285

    Timestamps

    Event (reported)
    Mar 3, 2026
    Published
    Apr 7, 2026
    Ingested by INSIDER
    Nov 5, 06:47 UTC
    Last re-read
    Nov 5, 06:47 UTC

    Extracted facts

    Filer
    Gilbert Ray Cisneros, Jr.
    Role
    Self
    Transaction
    PurchaseAs filed: “P”
    Asset
    Veracyte, Inc. - Common Stock
    Ticker
    VCYT
    Reported value
    $1,001 – $15KAs filed: “$1,001 - $15,000”
    Execution date (reported)
    Mar 3, 2026
    Notification date (reported)
    Apr 6, 2026
    Days from execution to publication
    35

    Calculation

    Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.

    • Low: $1,001
    • High: $15,000

    = $8,001

    What this establishes

    Gilbert Ray Cisneros, Jr. reported a purchase of Veracyte, Inc. - Common Stock. Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.

    Extraction

    Method
    PDF text extraction
    Confidence
    1.00
    Self
    Gilbert Ray Cisneros, Jr.bioguide:C001123
    Issuer
    VERACYTE, INC.cik:0001384101

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.